|Products||HealthTEST Rheumatoid Factor Assay|
|Item||HealthTEST Rheumatoid Factor Assay|
|Features||Currently 70% of in vitro diagnostic testing in the United States is perfomed by skilled technicians in laboratories. But with new technologies, like the Akers PIFA technology, and public pressure to cut costs, healthcare providers have begun a major shift to alternate site testing. Our HealthTEST product line is strategically positioned to take advantage of this profound changes in medical care.|
|Description|| At Akers, our ultimate goal is to provide state-of-the-art rapid diagnostic products for early detection and immediate treatment. Each year millions of people around the world unnecessarily suffer and die from late detection or undetected disease and illness. Diseases that destroy lives and cripple nations.
By developing, manufacturing and marketing our tests to point-of-care markets, such as physician's offices, hospitals, emergency care, managed care facilities, clinics and mobile Biosciences, Akers is providing fast, low-cost and accurate detection devices that can be used on the spot and in every corner of the globe.
Akers' proprietary PIFA technology provides a single platform for the development of multiple diagnostic tests, 30 separate tests either have been developed or are currently under development.
|Info|| Akers Biosciences|
Customer Service: (856) 848-8698
Web site: http://www.akerslaboratories.com